Do I need an in-person exam for Mounjaro in Texas?

If you’ve been considering GLP-1 medications like Wegovy, Ozempic, or Mounjaro for weight management, you’ve probably wondered: Can I get these prescribed through telehealth? The short answer is yes—in most cases, you absolutely can. But the details matter, especially depending on where you live.

This guide breaks down everything you need to know about accessing weight loss medications via telehealth in 2025, including federal rules, state-specific requirements, and what to expect during your virtual consultation.

Understanding Federal Telehealth Rules for Weight Loss Medications

Here’s the good news: GLP-1 medications for weight loss are not controlled substances under federal law. This is a crucial distinction that many people don’t realize.

The federal Ryan Haight Act—which requires an in-person exam before prescribing controlled substances via telemedicine—does not apply to medications like Wegovy (semaglutide), Ozempic (semaglutide), or Mounjaro (tirzepatide). These are non-controlled prescription medications, meaning there’s no federal barrier preventing a licensed healthcare provider from prescribing them after a telehealth consultation.

The Current Regulatory Landscape

While controlled substances (like ADHD medications or certain pain medications) are subject to temporary COVID-era flexibilities that the DEA extended through December 31, 2025, weight loss medications have never been restricted in this way at the federal level. The DEA’s telemedicine extensions primarily affect drugs like Adderall or buprenorphine—not the anti-obesity medications we’re discussing here.

Bottom line: Federal law allows telehealth prescribing of GLP-1 weight loss medications nationwide, as long as the provider is properly licensed and establishes an appropriate patient-provider relationship.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-Specific Requirements: What You Need to Know

While federal law permits telehealth prescribing of these medications, individual states have their own additional requirements. Some states require extra steps to ensure patient safety and proper medical oversight.

States Requiring Initial In-Person Exams

A handful of states mandate that patients have an in-person physical examination before or shortly after starting weight loss medication via telehealth:

Arkansas has some of the strictest telemedicine regulations in the country. Providers must conduct an initial in-person exam to establish a valid patient-provider relationship before prescribing weight loss medications via telehealth.

Delaware requires an initial physical examination in person before providers can prescribe these medications through telehealth channels.

Georgia mandates an in-person exam prior to telehealth prescribing. However, the state recently expanded prescriptive authority: as of July 2024, nurse practitioners and physician assistants can now prescribe Schedule II controlled substances with proper physician delegation—a significant expansion of access.

Mississippi requires patients to be seen in person at least once before weight management therapy can continue via telehealth.

New Jersey has particularly comprehensive requirements: state medical board rules require an extensive initial evaluation including a complete physical exam, laboratory work, psychological screening, and informed consent discussing all risks associated with weight loss therapy.

North Dakota expects a hands-on initial evaluation for weight loss treatment, though telehealth follow-ups are permitted.

South Carolina requires an initial in-person visit and periodic evaluations throughout treatment.

Texas generally expects an in-person exam before prescribing weight loss medications, though the state has broad telehealth allowances. Texas also has strict oversight of nurse practitioner prescribing—NPs must have a formal physician agreement and cannot practice independently.

Virginia has detailed regulations requiring an initial comprehensive work-up including physical examination, lab tests, and a personalized diet and exercise plan. The state also mandates a follow-up visit within 30 days of starting therapy.

States with Full Telehealth Access (No In-Person Requirement)

Many states fully embrace telehealth for weight management without requiring initial in-person visits:

California explicitly permits telehealth exams as sufficient for establishing care. Nurse practitioners in California have gained full independent practice authority (after 3+ years of experience), making access even easier.

Connecticut has permanent telehealth laws with no in-person mandate. The state does require that obesity treatment include behavioral counseling and a diet/exercise plan alongside medication.

Florida allows telehealth prescribing without requiring a physical in-person exam. However, Florida imposes specific conditions: patients must have a BMI ≥30, and follow-up visits are required at least every three months during treatment.

Illinois has no in-person requirements and permanent telehealth laws in place.

New York allows full telehealth access with no special restrictions on weight loss prescribing. Nurse practitioners have independent practice authority after completing 3,600 hours of supervised practice.

Pennsylvania permits telehealth prescribing with no in-person mandate, though nurse practitioners still require physician collaboration agreements.

Utah encourages an initial in-person exam but doesn’t legally require it. The state recently expanded nurse practitioner autonomy (2023), improving access.

Washington is a pioneer in telehealth with full independent nurse practitioner practice. There are no in-person requirements for weight loss medication prescribing. The state’s My Health My Data Act (2023) adds important privacy protections for telehealth patients.

Who Can Prescribe Weight Loss Medications Via Telehealth?

Physicians (MD/DO)

All states allow licensed medical doctors and doctors of osteopathic medicine to prescribe GLP-1 weight loss medications via telehealth, provided they’re licensed in the state where the patient is physically located during the consultation.

Nurse Practitioners (NPs)

Nurse practitioner prescribing authority varies significantly by state:

Full Independent Practice States: In states like California, New York, Washington, Arizona, and Utah, nurse practitioners can prescribe these medications independently without physician oversight (typically after meeting experience requirements of 2-3 years).

Collaborative Practice States: States like Florida, Pennsylvania, Illinois, and Georgia require nurse practitioners to have collaboration agreements or supervisory relationships with physicians, but NPs can still prescribe weight loss medications within those frameworks.

Restricted Practice States: Very few states significantly restrict NP prescribing for non-controlled medications. Even in more restrictive states like Texas, NPs can prescribe GLP-1 medications with proper physician delegation agreements.

Physician Assistants (PAs)

Physician assistants can prescribe weight loss medications in all states, though they typically work under physician supervision or collaboration agreements. The scope varies by state, but PAs are well-positioned to provide telehealth weight management services.

What to Expect During a Telehealth Weight Loss Consultation

Reputable telehealth providers follow a thorough evaluation process to ensure these powerful medications are appropriate and safe for you.

Medical History and Screening

Your provider will conduct a comprehensive medical history review, including:

• Current height, weight, and BMI calculation
• Previous weight loss attempts and methods
• Complete medication list (to check for interactions)
• Medical conditions, especially thyroid disorders, pancreatitis history, or gallbladder disease
• Family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Pregnancy status or plans (GLP-1s are contraindicated in pregnancy)

Clinical Eligibility Criteria

To qualify for GLP-1 weight loss medications, you generally need:

• BMI ≥30 (classified as obese), OR
• BMI ≥27 with at least one weight-related health condition such as type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea
• Evidence of previous lifestyle modification attempts (diet and exercise)
• No contraindications (history of medullary thyroid cancer, MEN2, severe GI disorders, active gallbladder disease, pregnancy)

The Treatment Plan

A comprehensive weight management plan includes more than just medication. Your provider should discuss:

Lifestyle modifications: Diet and exercise recommendations tailored to your situationMedication education: How to self-inject, what to expect, potential side effectsFollow-up schedule: Regular check-ins (typically monthly initially, then every 2-3 months)Lab monitoring: Baseline labs and periodic monitoring of metabolic panels, liver function, and potentially A1C

Informed Consent

Quality telehealth providers will ensure you understand:

• Common side effects (nausea, GI upset, potential for pancreatitis or gallstones)
• The gradual nature of weight loss (typically over several months)
• The importance of lifestyle changes alongside medication
• Cost considerations and insurance coverage
• What happens if you stop the medication

Common Medications Prescribed Via Telehealth

Wegovy (Semaglutide 2.4mg)

FDA Status: Approved specifically for chronic weight management in adults with obesity or overweight with comorbidities

How It Works: Weekly self-injection that mimics GLP-1, a hormone that regulates appetite and food intake

Typical Results: Average weight loss of 12-15% of body weight over 68 weeks when combined with lifestyle changes

Telehealth Availability: Widely available through telehealth in all states (subject to state-specific requirements outlined above)

Important Note: As of May 2025, the FDA banned routine compounding of semaglutide for weight loss due to safety concerns and the end of the drug shortage. Only FDA-approved, brand-name Wegovy should be prescribed.

Ozempic (Semaglutide 0.5-1mg)

FDA Status: Approved for type 2 diabetes; commonly used off-label for weight loss

Telehealth Considerations: Providers can prescribe Ozempic via telehealth for weight loss as an off-label use, but must document the rationale and obtain informed consent. The same active ingredient as Wegovy, just at different dosing.

When It’s Used: Often prescribed when Wegovy is unavailable or not covered by insurance, though this practice has become less common as Wegovy supply has stabilized.

Mounjaro/Zepbound (Tirzepatide)

FDA Status: Mounjaro is approved for type 2 diabetes; Zepbound (same medication) was approved for obesity in late 2023

How It Works: Dual agonist targeting both GLP-1 and GIP receptors, potentially offering even greater weight loss than semaglutide

Telehealth Availability: Can be prescribed via telehealth for qualified patients. Providers must use the obesity-specific branding (Zepbound) when prescribing specifically for weight management, or document off-label use of Mounjaro.

Supply Considerations: Typically dispensed as 4-week ‘titration packs’ to help patients adjust to increasing doses.

How Klarity Health Makes Telehealth Weight Management Accessible

At Klarity Health, we’ve designed our weight management program to combine convenience with comprehensive care:

Licensed Providers in Your State: All our healthcare providers are licensed in the states where we operate, ensuring full compliance with local regulations—whether that means coordinating an initial in-person exam in states that require it, or providing fully virtual care where permitted.

Transparent Pricing: We believe in upfront, honest pricing with no surprise fees. We accept both insurance and cash pay options, making treatment accessible regardless of your coverage situation.

Quick Availability: We know that when you’re ready to start your weight loss journey, waiting weeks for an appointment can be discouraging. Klarity offers same-day or next-day appointments in most cases, getting you started faster than traditional clinics.

Ongoing Support: Weight management isn’t a one-time prescription—it’s an ongoing journey. Our providers schedule regular follow-ups to monitor your progress, adjust dosing, manage side effects, and provide the encouragement you need to succeed.

Comprehensive Approach: We don’t just hand out prescriptions. Our team helps you develop sustainable lifestyle changes, provides nutritional guidance, and addresses the psychological aspects of weight management.

Red Flags: How to Spot Questionable Telehealth Services

Unfortunately, the popularity of weight loss medications has attracted some less-than-reputable operators. Be cautious of any service that:

Guarantees a prescription without evaluation: No legitimate provider can promise you’ll get a prescription before reviewing your medical history and determining if you’re a good candidate.

Offers compounded or ‘generic’ versions: Since May 2025, the FDA has prohibited routine compounding of semaglutide. Only FDA-approved medications should be prescribed. Overseas or compound versions may be unsafe or ineffective.

Skips follow-up care: Safe weight management requires regular monitoring. Services that don’t schedule follow-ups or check on your progress are cutting dangerous corners.

Lacks transparency about provider credentials: You should always know who your provider is, what their qualifications are, and what state they’re licensed in.

Pressures you or uses high-pressure sales tactics: Legitimate healthcare providers educate and empower—they don’t pressure you into treatment.

Has no clear physical address or clinic affiliation: Fly-by-night operations often hide behind websites without legitimate clinic credentials.

Insurance Coverage and Cost Considerations

Insurance Coverage

Coverage for GLP-1 weight loss medications varies widely:

Medicare: Traditional Medicare (Part B) does not cover weight loss medications. However, some Medicare Advantage plans do offer coverage.

Private Insurance: Coverage is inconsistent. Some plans cover Wegovy or Zepbound with prior authorization, especially if you have obesity-related health conditions. Others exclude weight loss medications entirely from their formularies.

Medicaid: Coverage varies by state. Some state Medicaid programs cover anti-obesity medications; others don’t.

Prior Authorization

If your insurance does cover these medications, expect to navigate prior authorization requirements, which typically include:

• Documentation of BMI ≥30 (or ≥27 with comorbidities)
• Records of previous weight loss attempts
• Letter of medical necessity from your provider
• Sometimes, proof of participation in a lifestyle modification program

Klarity Health can help navigate this process, providing the documentation your insurance company requires.

Self-Pay Options

If insurance doesn’t cover your medication or prior authorization is denied, self-pay options exist:

Manufacturer savings programs: Novo Nordisk (Wegovy, Ozempic) and Eli Lilly (Mounjaro/Zepbound) offer savings cards that can significantly reduce costs for eligible patients.

Cash-pay pricing: Varies by pharmacy and medication, but expect $900-$1,400 per month for brand-name products without insurance.

Klarity’s transparent pricing: We’re upfront about all costs—both for the consultation and medication—so you can make informed decisions about your care.

The Future of Telehealth Weight Management

The regulatory landscape continues to evolve in favor of expanded telehealth access:

Federal Legislation: The TREATS Act, reintroduced in Congress in October 2025, would permanently expand telehealth flexibilities for certain prescriptions, signaling continued federal support for telemedicine.

State Modernization: More states are updating outdated laws that restricted telehealth. We anticipate several states will ease nurse practitioner practice restrictions in 2026, further expanding access.

Improved Access: The trajectory is clear—regulators recognize that requiring in-person visits can be a significant barrier to obesity treatment, particularly for rural patients or those with mobility challenges.

Technology Integration: Expect to see better integration of remote monitoring (smart scales, continuous glucose monitors, activity trackers) with telehealth platforms, allowing for even more comprehensive virtual care.

Taking the Next Step

If you’re ready to explore whether telehealth weight loss treatment is right for you, here’s what to do:

Check your state’s requirements: Use the guide above to understand what’s required where you live. Don’t let complex regulations discourage you—services like Klarity Health handle the compliance details for you.

Gather your information: Have your current weight, height, medical history, and current medications ready. If you have recent lab work, that’s helpful too.

Schedule a consultation: At Klarity Health, you can book a same-day or next-day appointment with a licensed provider in your state. The consultation is thorough but efficient, typically lasting 20-30 minutes.

Discuss your options: Your provider will review whether you’re a good candidate, discuss which medication might be best for your situation, and create a personalized treatment plan.

Start your journey: If approved, your prescription is sent electronically to your pharmacy of choice. Your provider will schedule your follow-up visits and remain available for questions throughout your treatment.

Conclusion: Telehealth Opens Doors to Evidence-Based Weight Management

The answer to ‘Can you get weight loss medication through telehealth?’ is a resounding yes for most Americans—with some state-specific variations that quality providers like Klarity Health expertly navigate.

Telehealth has democratized access to evidence-based obesity treatment, removing geographical barriers and reducing the stigma that sometimes accompanies in-person weight loss consultations. Combined with comprehensive lifestyle support, medications like Wegovy, Ozempic, and Mounjaro can be powerful tools in achieving sustainable weight loss.

The key is working with a reputable provider who prioritizes your safety, provides ongoing support, and operates with full transparency about costs and treatment expectations. Klarity Health checks all these boxes, offering licensed provider availability, transparent pricing, and acceptance of both insurance and cash pay—all designed to make your weight loss journey as smooth as possible.

Ready to take the first step? Schedule your consultation with Klarity Health today and discover how telehealth weight management can work for you.

Frequently Asked Questions

Q: Will I definitely get a prescription if I have a telehealth consultation?

A: No. Reputable providers conduct a thorough evaluation to determine if you’re a good candidate. You’ll only receive a prescription if you meet clinical criteria and have no contraindications. This protects your safety.

Q: How long does the initial telehealth visit take?

A: Most initial consultations last 20-30 minutes, during which your provider reviews your medical history, discusses your weight loss goals, and determines the best treatment approach.

Q: Can my regular doctor prescribe these medications via telehealth, or do I need a special weight loss clinic?

A: If your regular doctor offers telehealth services and is comfortable prescribing weight loss medications, they can absolutely do so (subject to your state’s rules). However, specialized weight management programs like Klarity often have more experience with these medications and comprehensive support programs.

Q: What happens if I move to a different state during treatment?

A: Your provider must be licensed in the state where you’re physically located. If you move, you may need to transfer care to a provider licensed in your new state. Klarity Health operates in multiple states, which can make this transition smoother.

Q: Are telehealth consultations as effective as in-person visits for weight loss treatment?

A: Research shows that telehealth weight management programs can be equally effective as in-person care when they include comprehensive support, regular monitoring, and appropriate follow-up—all elements that quality programs provide.

📅 RESEARCH CURRENCY STATEMENT
Verified as of: December 17, 2025
DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.
States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of Dec 2025)

References

1. DEA and HHS Extend Telemedicine Flexibilities through 2025 – U.S. Drug Enforcement Administration official announcement, November 15, 2024. Available at: www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025

2. ‘COVID-era telehealth prescribing extended’ – Axios News, November 18, 2024. Available at: www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall

3. ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025’ – McDermott Will & Emery legal analysis, November 18, 2024. Available at: www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025

4. ‘The Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs’ – Goodwin Procter LLP client alert, March 27, 2024. Available at: www.goodwinlaw.com/en/insights/publications/2024/03/alerts-lifesciences-hltc-changing-regulatory-reimbursement-weight-loss-drugs

5. ‘Know Your State’s Laws Around Semaglutide Prescribing and Administration’ – Nextech healthcare blog, April 11, 2025. Available at: www.nextech.com/blog/semaglutide-laws-by-state

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid